Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer.
Dalal K, Roshan-Moniri M, Sharma A, Li H, Ban F, Hassona MD, Hsing M, Singh K, LeBlanc E, Dehm S, Tomlinson Guns ES, Cherkasov A, Rennie PS.
Dalal K, et al. Among authors: cherkasov a.
J Biol Chem. 2015 Oct 23;290(43):25850. doi: 10.1074/jbc.A115.553818.
J Biol Chem. 2015.
PMID: 26500294
Free PMC article.
No abstract available.